LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 94

Search options

  1. Article ; Online: Macrophage Nrf2, an anti-inflammatory signal in hepatic ischemia/reperfusion injury.

    Jiang, Joy X

    Cellular & molecular immunology

    2023  Volume 20, Issue 5, Page(s) 427–428

    MeSH term(s) Humans ; NF-E2-Related Factor 2 ; Liver ; Reperfusion Injury ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use ; Macrophages ; Ischemia
    Chemical Substances NF-E2-Related Factor 2 ; Anti-Inflammatory Agents
    Language English
    Publishing date 2023-01-05
    Publishing country China
    Document type Journal Article
    ZDB-ID 2435097-7
    ISSN 2042-0226 ; 1672-7681
    ISSN (online) 2042-0226
    ISSN 1672-7681
    DOI 10.1038/s41423-022-00964-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Shc inhibitor idebenone ameliorates liver injury and fibrosis in dietary NASH in mice.

    Jiang, Joy X / Tomilov, Alexey / Montgomery, Claire / Hui, Chun Kui / Török, Natalie J / Cortopassi, Gino

    Journal of biochemical and molecular toxicology

    2021  Volume 35, Issue 10, Page(s) e22876

    Abstract: Shc expression rises in human nonalcoholic steatohepatitis (NASH) livers, and Shc-deficient mice are protected from NASH-thus Shc inhibition could be a novel therapeutic strategy for NASH. Idebenone was recently identified as the first small-molecule Shc ...

    Abstract Shc expression rises in human nonalcoholic steatohepatitis (NASH) livers, and Shc-deficient mice are protected from NASH-thus Shc inhibition could be a novel therapeutic strategy for NASH. Idebenone was recently identified as the first small-molecule Shc inhibitor drug. We tested idebenone in the fibrotic methionine-choline deficient (MCD) diet and the metabolic fast food diet (FFD) mouse models of NASH. In the fibrotic MCD NASH model, idebenone reduced Shc expression and phosphorylation in peripheral blood mononuclear cells and Shc expression in the liver; decreased serum alanine aminotransferase and aspartate aminotransferase; and attenuated liver fibrosis as observed by quantitative polymerase chain reaction (qPCR) and hydroxyproline quantification. In the metabolic FFD model, idebenone administration improved insulin resistance, and reduced inflammation and fibrosis shown with qPCR, hydroxyproline measurement, and histology. Thus, idebenone ameliorates NASH in two mouse models. As an approved drug with a benign safety profile, Idebenone could be a reasonable human NASH therapy.
    MeSH term(s) Alanine Transaminase/blood ; Animals ; Aspartate Aminotransferases/blood ; Choline Deficiency/complications ; Diet/adverse effects ; Disease Models, Animal ; Fast Foods/adverse effects ; Leukocytes, Mononuclear/metabolism ; Liver/injuries ; Liver/metabolism ; Liver Cirrhosis/blood ; Liver Cirrhosis/complications ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/etiology ; Male ; Methionine/deficiency ; Mice ; Mice, Inbred C57BL ; Non-alcoholic Fatty Liver Disease/blood ; Non-alcoholic Fatty Liver Disease/complications ; Non-alcoholic Fatty Liver Disease/drug therapy ; Non-alcoholic Fatty Liver Disease/etiology ; Phosphorylation/drug effects ; Protective Agents/administration & dosage ; Shc Signaling Adaptor Proteins/antagonists & inhibitors ; Shc Signaling Adaptor Proteins/metabolism ; Signal Transduction/drug effects ; Therapeutics ; Ubiquinone/administration & dosage ; Ubiquinone/analogs & derivatives
    Chemical Substances Protective Agents ; Shc Signaling Adaptor Proteins ; Ubiquinone (1339-63-5) ; Methionine (AE28F7PNPL) ; Aspartate Aminotransferases (EC 2.6.1.1) ; Alanine Transaminase (EC 2.6.1.2) ; idebenone (HB6PN45W4J)
    Language English
    Publishing date 2021-08-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1410020-4
    ISSN 1099-0461 ; 1095-6670
    ISSN (online) 1099-0461
    ISSN 1095-6670
    DOI 10.1002/jbt.22876
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: NADPH Oxidases in Chronic Liver Diseases.

    Jiang, Joy X / Török, Natalie J

    Advances in hepatology

    2015  Volume 2014

    Abstract: Oxidative stress is a common feature observed in a wide spectrum of chronic liver diseases including viral hepatitis, alcoholic, and nonalcoholic steatohepatitis. The nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOXs) are emerging as ... ...

    Abstract Oxidative stress is a common feature observed in a wide spectrum of chronic liver diseases including viral hepatitis, alcoholic, and nonalcoholic steatohepatitis. The nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOXs) are emerging as major sources of reactive oxygen species (ROS). Several major isoforms are expressed in the liver, including NOX1, NOX2, and NOX4. While the phagocytic NOX2 has been known to play an important role in Kupffer cell and neutrophil phagocytic activity and inflammation, the nonphagocytic NOX homologues are increasingly recognized as key enzymes in oxidative injury and wound healing. In this review, we will summarize the current advances in knowledge on the regulatory pathways of NOX activation, their cellular distribution, and their role in the modulation of redox signaling in liver diseases.
    Language English
    Publishing date 2015-02-08
    Publishing country Egypt
    Document type Journal Article
    ZDB-ID 2824230-0
    ISSN 2314-7709 ; 2356-6744
    ISSN (online) 2314-7709
    ISSN 2356-6744
    DOI 10.1155/2014/742931
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: MLK3 as a regulator of disease progression in Non-alcoholic steatohepatitis.

    Jiang, Joy X / Török, Natalie J

    Liver international : official journal of the International Association for the Study of the Liver

    2014  Volume 34, Issue 8, Page(s) 1131–1132

    MeSH term(s) Animals ; Disease Progression ; Humans ; MAP Kinase Kinase Kinases/metabolism ; MAP Kinase Signaling System/physiology ; Mice ; Mitogen-Activated Protein Kinase 8/metabolism ; Non-alcoholic Fatty Liver Disease/metabolism ; Non-alcoholic Fatty Liver Disease/physiopathology ; Mitogen-Activated Protein Kinase Kinase Kinase 11
    Chemical Substances Mitogen-Activated Protein Kinase 8 (EC 2.7.11.24) ; MAP Kinase Kinase Kinases (EC 2.7.11.25)
    Language English
    Publishing date 2014-03-13
    Publishing country United States
    Document type Editorial
    ZDB-ID 2102783-3
    ISSN 1478-3231 ; 1478-3223
    ISSN (online) 1478-3231
    ISSN 1478-3223
    DOI 10.1111/liv.12556
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Liver Injury and the Activation of the Hepatic Myofibroblasts.

    Jiang, Joy X / Török, Natalie J

    Current pathobiology reports

    2013  Volume 1, Issue 3, Page(s) 215–223

    Abstract: Liver fibrosis is a wound healing process, the end result of chronic liver injury elicited by different noxious stimuli. Activated hepatic stellate cells or myofibroblasts and portal myofibroblasts are considered as the main producers of the ... ...

    Abstract Liver fibrosis is a wound healing process, the end result of chronic liver injury elicited by different noxious stimuli. Activated hepatic stellate cells or myofibroblasts and portal myofibroblasts are considered as the main producers of the extracellular matrix in the liver. Upon liver injury the quiescent stellate cells transdifferentiate into myofibroblasts a process highlighted by the loss of vitamin A stores, upregulation of interstitial type collagens, smooth muscle α actin, matrix metalloproteinases, proteoglycans, and the induction of cell survival pathways. Activation of hepatic stellate cells is a result of a complex interplay between the parenchymal cells, immune cells, extracellular matrix mechanics and extrahepatic milieu such as the gut microbiome. In this review we will focus on the pathomechanism of stellate cell activation following chronic liver injury; with the aim of identifying possible treatment targets for anti-fibrogenic agents.
    Language English
    Publishing date 2013-08-14
    Publishing country United States
    Document type Journal Article
    ISSN 2167-485X
    ISSN 2167-485X
    DOI 10.1007/s40139-013-0019-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Shc Is Implicated in Calreticulin-Mediated Sterile Inflammation in Alcoholic Hepatitis.

    Li, Yuan / Jiang, Joy X / Fan, Weiguo / Fish, Sarah R / Das, Suvarthi / Gupta, Parul / Mozes, Gergely / Vancza, Lorand / Sarkar, Sutapa / Kunimoto, Koshi / Chen, Dongning / Park, Hyesuk / Clemens, Dahn / Tomilov, Alexey / Cortopassi, Gino / Török, Natalie J

    Cellular and molecular gastroenterology and hepatology

    2022  Volume 15, Issue 1, Page(s) 197–211

    Abstract: ... as well as cleaved caspase 8, B-cell-receptor-associated protein 31 (BAP31), Bcl-2-associated X protein ... 1β, monocyte chemoattractant protein 1, and C-X-C chemokine ligand 10 were reduced in Shc knockdown ...

    Abstract Background & aims: Src homology and collagen (Shc) proteins are major adapters to extracellular signals, however, the regulatory role of Shc isoforms in sterile inflammatory responses in alcoholic hepatitis (AH) has not been fully investigated. We hypothesized that in an isoform-specific manner Shc modulates pre-apoptotic signals, calreticulin (CRT) membrane exposure, and recruitment of inflammatory cells.
    Methods: Liver biopsy samples from patients with AH vs healthy subjects were studied for Shc expression using DNA microarray data and immunohistochemistry. Shc knockdown (hypomorph) and age-matched wild-type mice were pair-fed according to the chronic-plus-binge alcohol diet. To analyze hepatocyte-specific effects, adeno-associated virus 8-thyroxine binding globulin-Cre (hepatocyte-specific Shc knockout)-mediated deletion was performed in flox/flox Shc mice. Lipid peroxidation, proinflammatory signals, redox radicals, reduced nicotinamide adenine dinucleotide/oxidized nicotinamide adenine dinucleotide ratio, as well as cleaved caspase 8, B-cell-receptor-associated protein 31 (BAP31), Bcl-2-associated X protein (Bax), and Bcl-2 homologous antagonist killer (Bak), were assessed in vivo. CRT translocation was studied in ethanol-exposed p46ShcẟSH2-transfected hepatocytes by membrane biotinylation in conjunction with phosphorylated-eukaryotic initiation factor 2 alpha, BAP31, caspase 8, and Bax/Bak. The effects of idebenone, a novel Shc inhibitor, was studied in alcohol/pair-fed mice.
    Results: Shc was significantly induced in patients with AH (P < .01). Alanine aminotransferase, reduced nicotinamide adenine dinucleotide/oxidized nicotinamide adenine dinucleotide ratios, production of redox radicals, and lipid peroxidation improved (P < .05), and interleukin 1β, monocyte chemoattractant protein 1, and C-X-C chemokine ligand 10 were reduced in Shc knockdown and hepatocyte-specific Shc knockout mice. In vivo, Shc-dependent induction, and, in hepatocytes, a p46Shc-dependent increase in pre-apoptotic proteins Bax/Bak, caspase 8, BAP31 cleavage, and membrane translocation of CRT/endoplasmic reticulum-resident protein 57 were seen. Idebenone protected against alcohol-mediated liver injury.
    Conclusions: Alcohol induces p46Shc-dependent activation of pre-apoptotic pathways and translocation of CRT to the membrane, where it acts as a damage-associated molecular pattern, instigating immunogenicity. Shc inhibition could be a novel treatment strategy in AH.
    MeSH term(s) Mice ; Animals ; bcl-2-Associated X Protein ; Hepatitis, Alcoholic ; Caspase 8 ; Calreticulin ; NAD ; Mice, Knockout ; Ethanol ; Inflammation ; Collagen
    Chemical Substances bcl-2-Associated X Protein ; Caspase 8 (EC 3.4.22.-) ; Calreticulin ; NAD (0U46U6E8UK) ; Ethanol (3K9958V90M) ; Collagen (9007-34-5)
    Language English
    Publishing date 2022-09-17
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2819778-1
    ISSN 2352-345X ; 2352-345X
    ISSN (online) 2352-345X
    ISSN 2352-345X
    DOI 10.1016/j.jcmgh.2022.09.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: AGER1 downregulation associates with fibrosis in nonalcoholic steatohepatitis and type 2 diabetes.

    Dehnad, Ali / Fan, Weiguo / Jiang, Joy X / Fish, Sarah R / Li, Yuan / Das, Suvarthi / Mozes, Gergely / Wong, Kimberly A / Olson, Kristin A / Charville, Gregory W / Ali, Mohammed / Török, Natalie J

    The Journal of clinical investigation

    2020  Volume 130, Issue 8, Page(s) 4320–4330

    Abstract: Type 2 diabetes is clinically associated with progressive necroinflammation and fibrosis in nonalcoholic steatohepatitis (NASH). Advanced glycation end-products (AGEs) accumulate during prolonged hyperglycemia, but the mechanistic pathways that lead to ... ...

    Abstract Type 2 diabetes is clinically associated with progressive necroinflammation and fibrosis in nonalcoholic steatohepatitis (NASH). Advanced glycation end-products (AGEs) accumulate during prolonged hyperglycemia, but the mechanistic pathways that lead to accelerated liver fibrosis have not been well defined. In this study, we show that the AGEs clearance receptor AGER1 was downregulated in patients with NASH and diabetes and in our NASH models, whereas the proinflammatory receptor RAGE was induced. These findings were associated with necroinflammatory, fibrogenic, and pro-oxidant activity via the NADPH oxidase 4. Inhibition of AGEs or RAGE deletion in hepatocytes in vivo reversed these effects. We demonstrate that dysregulation of NRF2 by neddylation of cullin 3 was linked to AGER1 downregulation and that induction of NRF2 using an adeno-associated virus-mediated approach in hepatocytes in vivo reversed AGER1 downregulation, lowered the level of AGEs, and improved proinflammatory and fibrogenic responses in mice on a high AGEs diet. In patients with NASH and diabetes or insulin resistance, low AGER1 levels were associated with hepatocyte ballooning degeneration and ductular reaction. Collectively, prolonged exposure to AGEs in the liver promotes an AGER1/RAGE imbalance and consequent redox, inflammatory, and fibrogenic activity in NASH.
    MeSH term(s) Animals ; Ascorbic Acid ; Cholecalciferol ; Dehydroepiandrosterone/analogs & derivatives ; Diabetes Mellitus, Type 2/genetics ; Diabetes Mellitus, Type 2/metabolism ; Diabetes Mellitus, Type 2/pathology ; Disease Models, Animal ; Down-Regulation ; Hepatocytes/metabolism ; Hepatocytes/pathology ; Liver Cirrhosis/genetics ; Liver Cirrhosis/metabolism ; Liver Cirrhosis/pathology ; Mice ; Mice, Knockout ; NF-E2-Related Factor 2/genetics ; NF-E2-Related Factor 2/metabolism ; Nicotinic Acids ; Non-alcoholic Fatty Liver Disease/genetics ; Non-alcoholic Fatty Liver Disease/metabolism ; Non-alcoholic Fatty Liver Disease/pathology ; Plant Extracts ; Receptor for Advanced Glycation End Products/biosynthesis ; Receptor for Advanced Glycation End Products/genetics
    Chemical Substances AGER protein, human ; Ager protein, mouse ; HUM 5007 ; NF-E2-Related Factor 2 ; NFE2L2 protein, human ; Nfe2l2 protein, mouse ; Nicotinic Acids ; Plant Extracts ; Receptor for Advanced Glycation End Products ; Cholecalciferol (1C6V77QF41) ; Dehydroepiandrosterone (459AG36T1B) ; Ascorbic Acid (PQ6CK8PD0R)
    Language English
    Publishing date 2020-07-13
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI133051
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Nonphagocytic Activation of NOX2 Is Implicated in Progressive Nonalcoholic Steatohepatitis During Aging.

    Jiang, Joy X / Fish, Sarah R / Tomilov, Alexey / Li, Yuan / Fan, Weiguo / Dehnad, Ali / Gae, David / Das, Suvarthi / Mozes, Gergely / Charville, Gregory W / Ramsey, Jon / Cortopassi, Gino / Török, Natalie J

    Hepatology (Baltimore, Md.)

    2020  Volume 72, Issue 4, Page(s) 1204–1218

    Abstract: Background and aims: Older patients with obesity/type II diabetes mellitus frequently present with advanced NASH. Whether this is due to specific molecular pathways that accelerate fibrosis during aging is unknown. Activation of the Src homology 2 ... ...

    Abstract Background and aims: Older patients with obesity/type II diabetes mellitus frequently present with advanced NASH. Whether this is due to specific molecular pathways that accelerate fibrosis during aging is unknown. Activation of the Src homology 2 domain-containing collagen-related (Shc) proteins and redox stress have been recognized in aging; however, their link to NASH has not been explored.
    Approach and results: Shc expression increased in livers of older patients with NASH, as assessed by real time quantitative PCR (RT-qPCR) or western blots. Fibrosis, Shc expression, markers of senescence, and nicotinamide adenine dinucleotide phosphate, reduced form oxidases (NOXs) were studied in young/old mice on fast food diet (FFD). To inhibit Shc in old mice, lentiviral (LV)-short hairpin Shc versus control-LV were used during FFD. For hepatocyte-specific effects, floxed (fl/fl) Shc mice on FFD were injected with adeno-associated virus 8-thyroxine-binding globulin-Cre-recombinase versus control. Fibrosis was accelerated in older mice on FFD, and Shc inhibition by LV in older mice or hepatocyte-specific deletion resulted in significantly improved inflammation, reduction in senescence markers in older mice, lipid peroxidation, and fibrosis. To study NOX2 activation, the interaction of p47
    Conclusions: Accelerated fibrosis in the aged is modulated by p52Shc/NOX2. We show a pathway for direct activation of the phagocytic NOX2 in hepatocytes by p52Shc binding and activating the p47
    MeSH term(s) Aging/metabolism ; Animals ; Hepatocytes/metabolism ; Humans ; Liver Cirrhosis/etiology ; Male ; Mice ; Mice, Inbred C57BL ; NADPH Oxidase 2/physiology ; NADPH Oxidases/metabolism ; Non-alcoholic Fatty Liver Disease/etiology ; Reactive Oxygen Species/metabolism ; Shc Signaling Adaptor Proteins/antagonists & inhibitors ; Shc Signaling Adaptor Proteins/physiology ; src Homology Domains
    Chemical Substances Reactive Oxygen Species ; Shc Signaling Adaptor Proteins ; Cybb protein, mouse (EC 1.6.3.-) ; NADPH Oxidase 2 (EC 1.6.3.-) ; NADPH Oxidases (EC 1.6.3.-) ; neutrophil cytosolic factor 1 (EC 1.6.3.1)
    Language English
    Publishing date 2020-10-09
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 604603-4
    ISSN 1527-3350 ; 0270-9139
    ISSN (online) 1527-3350
    ISSN 0270-9139
    DOI 10.1002/hep.31118
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Low-Level Saturated Fatty Acid Palmitate Benefits Liver Cells by Boosting Mitochondrial Metabolism via CDK1-SIRT3-CPT2 Cascade.

    Liu, Lin / Xie, Bowen / Fan, Ming / Candas-Green, Demet / Jiang, Joy X / Wei, Ryan / Wang, Yinsheng / Chen, Hong-Wu / Hu, Yiyang / Li, Jian Jian

    Developmental cell

    2019  Volume 52, Issue 2, Page(s) 196–209.e9

    Abstract: Saturated fatty acids (SFAs) (the "bad" fat), especially palmitate (PA), in the human diet are blamed for potential health risks such as obesity and cancer because of SFA-induced lipotoxicity. However, epidemiological results demonstrate a latent benefit ...

    Abstract Saturated fatty acids (SFAs) (the "bad" fat), especially palmitate (PA), in the human diet are blamed for potential health risks such as obesity and cancer because of SFA-induced lipotoxicity. However, epidemiological results demonstrate a latent benefit of SFAs, and it remains elusive whether a certain low level of SFAs is physiologically essential for maintaining cell metabolic hemostasis. Here, we demonstrate that although high-level PA (HPA) indeed induces lipotoxic effects in liver cells, low-level PA (LPA) increases mitochondrial functions and alleviates the injuries induced by HPA or hepatoxic agent carbon tetrachloride (CCl
    MeSH term(s) Animals ; CDC2 Protein Kinase/genetics ; CDC2 Protein Kinase/metabolism ; Carbon Tetrachloride/toxicity ; Carnitine O-Palmitoyltransferase/genetics ; Carnitine O-Palmitoyltransferase/metabolism ; Cells, Cultured ; Chemical and Drug Induced Liver Injury/drug therapy ; Chemical and Drug Induced Liver Injury/etiology ; Chemical and Drug Induced Liver Injury/metabolism ; Chemical and Drug Induced Liver Injury/pathology ; Hepatocytes/cytology ; Hepatocytes/drug effects ; Hepatocytes/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Mitochondria/drug effects ; Mitochondria/metabolism ; Mitochondria/pathology ; Palmitates/pharmacology ; Sirtuin 3/genetics ; Sirtuin 3/metabolism
    Chemical Substances Palmitates ; Sirt3 protein, mouse ; Carbon Tetrachloride (CL2T97X0V0) ; Carnitine O-Palmitoyltransferase (EC 2.3.1.21) ; CDC2 Protein Kinase (EC 2.7.11.22) ; Cdk1 protein, mouse (EC 2.7.11.22) ; Sirtuin 3 (EC 3.5.1.-)
    Language English
    Publishing date 2019-12-19
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2054967-2
    ISSN 1878-1551 ; 1534-5807
    ISSN (online) 1878-1551
    ISSN 1534-5807
    DOI 10.1016/j.devcel.2019.11.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Digoxin improves steatohepatitis with differential involvement of liver cell subsets in mice through inhibition of PKM2 transactivation.

    Zhao, Peng / Han, Sheng-Na / Arumugam, Suyavaran / Yousaf, Muhammad Nadeem / Qin, Yanqin / Jiang, Joy X / Torok, Natalie Julia / Chen, Yonglin / Mankash, Mohd Salah / Liu, Junbao / Li, Jiansheng / Iwakiri, Yasuko / Ouyang, Xinshou

    American journal of physiology. Gastrointestinal and liver physiology

    2019  Volume 317, Issue 4, Page(s) G387–G397

    Abstract: The cardiac glycoside digoxin was identified as a potent suppressor of pyruvate kinase isoform 2-hypoxia-inducible factor-α (PKM2-HIF-1α) pathway activation in liver injury mouse models via intraperitoneal injection. We have assessed the therapeutic ... ...

    Abstract The cardiac glycoside digoxin was identified as a potent suppressor of pyruvate kinase isoform 2-hypoxia-inducible factor-α (PKM2-HIF-1α) pathway activation in liver injury mouse models via intraperitoneal injection. We have assessed the therapeutic effects of digoxin to reduce nonalcoholic steatohepatitis (NASH) by the clinically relevant oral route in mice and analyzed the cellular basis for this effect with differential involvement of liver cell subsets. C57BL/6J male mice were placed on a high-fat diet (HFD) for 10 wk and started concurrently with the gavage of digoxin (2.5, 0.5, 0.125 mg/kg twice a week) for 5 wk. Digoxin significantly reduced HFD-induced hepatic damage, steatosis, and liver inflammation across a wide dosage range. The lowest dose of digoxin (0.125 mg/kg) showed significant protective effects against liver injury and sterile inflammation. Consistently, digoxin attenuated HIF-1α sustained NLRP3 inflammasome activation in macrophages. We have reported for the first time that PKM2 is upregulated in hepatocytes with hepatic steatosis, and digoxin directly improved hepatocyte mitochondrial dysfunction and steatosis. Mechanistically, digoxin directly bound to PKM2 and inhibited PKM2 targeting HIF-1α transactivation without affecting PKM2 enzyme activation. Thus, oral digoxin showed potential to therapeutically inhibit liver injury in NASH through the regulation of PKM2-HIF-1α pathway activation with involvement of multiple cell types. Because of the large clinical experience with oral digoxin, this may have significant clinical applicability in human NASH.
    MeSH term(s) Animals ; Cell Line ; Diet, High-Fat ; Digoxin/therapeutic use ; Enzyme Inhibitors/therapeutic use ; Hepatitis/pathology ; Hepatocytes/drug effects ; Hepatocytes/enzymology ; Humans ; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; NLR Family, Pyrin Domain-Containing 3 Protein/metabolism ; Non-alcoholic Fatty Liver Disease/drug therapy ; Non-alcoholic Fatty Liver Disease/pathology ; Oxidative Stress/drug effects ; Pyruvate Kinase/antagonists & inhibitors ; Pyruvate Kinase/metabolism ; Transcriptional Activation/drug effects
    Chemical Substances Enzyme Inhibitors ; Hif1a protein, mouse ; Hypoxia-Inducible Factor 1, alpha Subunit ; NLR Family, Pyrin Domain-Containing 3 Protein ; Nlrp3 protein, mouse ; Digoxin (73K4184T59) ; Pkm protein, mouse (EC 2.7.1.40) ; Pyruvate Kinase (EC 2.7.1.40)
    Language English
    Publishing date 2019-08-14
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 603840-2
    ISSN 1522-1547 ; 0193-1857
    ISSN (online) 1522-1547
    ISSN 0193-1857
    DOI 10.1152/ajpgi.00054.2019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top